EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CHO cell engineering via targeted integration of circular miR-21 decoy using CRISPR/RMCE hybrid system

Setare Adibzadeh, Shahin Amiri, Farzaneh Barkhordari, Seyed Javad Mowla, Hadi Bayat, Samaneh Ghanbari, Faezeh Faghihi, Fatemeh Davami

Applied Microbiology and Biotechnology · 2024

DOI: 10.1007/s00253-024-13266-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, 2024. Verfasst von Setare Adibzadeh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran. Hauptthemen laut MEDLINE: Cricetulus, MicroRNAs, CRISPR-Cas Systems. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pasteur Institute of Iran.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chinese hamster ovary (CHO) cells, widely acknowledged as the preferred host system for industrial recombinant protein manufacturing, play a crucial role in developing pharmaceuticals, including anticancer therapeutics. Nevertheless, mammalian cell-based biopharmaceutical production methods are still beset by cellular constraints such as limited growth and poor productivity. MicroRNA-21 (miR-21) has a major impact on a variety of malignancies, including glioblastoma multiforme (GBM). However, reduced productivity and growth rate have been linked to miR-21 overexpression in CHO cells. The current study aimed to engineer a recombinant CHO (rCHO) cell using the CRISPR-mediated precise integration into target chromosome (CRIS-PITCh) system coupled with the Bxb1 recombinase-mediated cassette exchange (RMCE) to express a circular miR-21 decoy (CM21D) with five bulged binding sites for miR-21 sponging. Implementing the ribonucleoprotein (RNP) delivery method, a landing pad was inserted into the genome utilizing the CRIS-PITCh technique. Subsequently, the CM21D cassette flanked by Bxb1 attB was then retargeted into the integrated landing pad using the RMCE/Bxb1 system. This strategy raised the targeting efficiency by 1.7-fold, and off-target effects were decreased. The miR-21 target genes ( Pdcd4 and Atp11b ) noticed a significant increase in expression upon the miR-21 sponging through CM21D. Following the expression of CM21D, rCHO cells showed a substantial decrease in doubling time and a 1.3-fold increase in growth rate. Further analysis showed an increased yield of hrsACE2, a secretory recombinant protein, by 2.06-fold. Hence, we can conclude that sponging-induced inhibition of miR-21 may lead to a growth rate increase that could be linked to increased CHO cell productivity. For industrial cell lines, including CHO cells, an increase in productivity is crucial. The results of our research indicate that CM21D is an auspicious CHO engineering approach. Key points • CHO is an ideal host cell line for producing industrial therapeutics manufacturing, and miR-21 is downregulated in CHO cells, which produce recombinant proteins. • The miR-21 target genes noticed a significant increase in expression upon the miR-21 sponging through CM21D. Additionally, sponging of miR-21 by CM21D enhanced the growth rate of CHO cells. • Productivity and growth rate were increased in CHO cells expressing recombinant hrs-ACE2 protein after CM21D knocking in. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CricetulusMicroRNAsCRISPR-Cas SystemsCHO CellsAnimalsCell EngineeringGene EditingRecombinant ProteinsRecombinasesCricetinae

Stichwörter der Autor:innen

CHOCRISPR-Cas9MicroRNAProductivityRMCE

Substanzen

MicroRNAsMIRN21 microRNA, humanRecombinant ProteinsRecombinases

Autor:innen und Institutionen

  • Department of Medical Biotechnology, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
  • Student Research Committee, Pasteur Institute of Iran, Tehran, Iran.
  • Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
  • Biochemical Neuroendocrinology, Institut de Recherches Cliniques de Montréal (IRCM), affiliated to the Division of Experimental Medicine, Faculty of Medicine and Health Sciences, McGill University, Montréal, H2W 1R7, Ca…
  • Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran. faezefaghihi@yahoo.com.
  • Department of Medical Biotechnology, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran. f.davami@gmail.com.

Förderung

  • Pasteur Institute of Iran

Zitieren

APA

Adibzadeh, S., Amiri, S., Barkhordari, F., Mowla, S. J., Bayat, H., Ghanbari, S., Faghihi, F., & Davami, F. (2024). CHO cell engineering via targeted integration of circular miR-21 decoy using CRISPR/RMCE hybrid system. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-024-13266-4

Vancouver

Adibzadeh S, Amiri S, Barkhordari F, Mowla SJ, Bayat H, Ghanbari S, et al. CHO cell engineering via targeted integration of circular miR-21 decoy using CRISPR/RMCE hybrid system. Applied Microbiology and Biotechnology. 2024. doi:10.1007/s00253-024-13266-4

BibTeX
@article{Adibzadeh2024,
  author = {Adibzadeh, Setare and Amiri, Shahin and Barkhordari, Farzaneh and Mowla, Seyed Javad and Bayat, Hadi and Ghanbari, Samaneh and Faghihi, Faezeh and Davami, Fatemeh},
  title = {CHO cell engineering via targeted integration of circular miR-21 decoy using CRISPR/RMCE hybrid system},
  journal = {Applied Microbiology and Biotechnology},
  year = {2024},
  doi = {10.1007/s00253-024-13266-4}
}
Kostenlos starten →